California Federal Court Denies Motion to Dismiss Securities Class Action Arising from Uber’s IPO; S.D.N.Y. Dismisses Ponzi Scheme Action Against HSBC Hong Kong for Lack of Personal Jurisdiction; Delaware Court of Chancery...more
8/27/2020
/ Advisory Committee ,
Appraisal Rights ,
Class Action ,
Dismissals ,
False Statements ,
Food and Drug Administration (FDA) ,
Initial Public Offering (IPO) ,
Investors ,
Legal Fees ,
Material Misrepresentation ,
Misleading Statements ,
Misrepresentation ,
Motion to Dismiss ,
Negligence ,
Omissions ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Ponzi Scheme ,
Putative Class Actions ,
Securities Act of 1933 ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Shareholders ,
Strict Liability ,
Uber